← Browse by Condition
Medical Condition

relapsed or refractory hodgkin s lymphoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT05300282 Phase 1, Phase 2
Recruiting

Study of Atezolizumab Plus BEGEV Regimen in Relapsed or Refractory Hodgkin's Lymphoma Patients

Enrollment
122 pts
Location
Italy
Sponsor
Fondazione Italiana Linfomi - ...
View Trial →